BIO-Europe Spring® 2017: Partnerships are key for rare disease drug discovery and development

April 11, 2017

What kinds of partnerships are key to getting rare disease research out of the lab and to patients as therapies and cures? Wendy White, Board Chairman of Global Genes, discusses her work on behalf of the leading global rare disease patient advocacy organization, and the impact patient advocacy groups are making on rare disease research.

 


EBD Group is committed to the rare disease community. To further partnering and collaboration opportunities between leaders from patient advocacy groups, industry, academia and government, the inaugural Cell & Gene Exchange event will be held in Washington, DC May 22–23, 2017. 

Previous Article
Report findings provide insight into technological innovations and trends in drug development
Report findings provide insight into technological innovations and trends in drug development

Knect365 Life Sciences has released a report offering unique insights into the awareness, perceptions and i...

Next Article
Using Partnerships, Hua Medicine Brings Novel Diabetes Drug to Phase III
Using Partnerships, Hua Medicine Brings Novel Diabetes Drug to Phase III

Li Chen, PhD, co-founded Hua Medicine (Shanghai) six years ago with Ge Li, PhD, founder of WuXi AppTec. The...